Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2000, No. 03
(2000; 24 pages)
Table of Contents
View the documentEditorial
Open this folder and view contentsRegulatory information
Open this folder and view contentsSafety of medicines
View the documentFeature: Direct reporting by consumers - First international conference, Sigtuna, Sweden
View the documentCounterfeit drugs - Data collection and the Liaison Officers network, WHO
 

WHO Pharmaceuticals Newsletter 2000, No. 03

prepared in collaboration with the
WHO Collaborating Centre for
International Drug Monitoring,
Uppsala, Sweden

No. 3, 2000

The aim of this Newsletter is to disseminate
information on the safety and efficacy of
pharmaceutical products, based on information
received from our network of “drug
information officers” and other sources such
as specialized bulletins and journals, as well
as partners in WHO. Information on
adverse drug reactions is provided by the
WHO Collaborating Centre for International Drug Monitoring.
The information is produced in the form of
résumés in English full texts of which may be
obtained on request from:

Quality Assurance and Safety:
Medicines, EDP-HTP
World Health Organization
1211 Geneva 27, Switzerland
E-mail address: QSM@who.int
Fax: +41 22 791 4730.

Extensive information on medicines may be
obtained from our Internet site:

http://www.who.int/medicines/

Further information on adverse reactions
may be obtained from the
WHO Collaborating Centre for
International Drug Monitoring,
Stora Target 3, S-753 20 Uppsala, Sweden
Tel: 46-18-65.60.60; Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org
Internet: http://www.who-umc.org

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014